MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.95
+0.42 (3.35%)
At close: Aug 13, 2025, 4:00 PM
12.95
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:48 PM EDT
Paragon 28 Market Cap
MBX Biosciences has a market cap or net worth of $436.22 million as of August 13, 2025.
Market Cap
436.22M
Enterprise Value
218.85M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.95
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $436.22M, a decrease of -14.41%. That is a compound annual growth rate of -15.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 435.04M | -29.36% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 585.32B |
| Johnson & Johnson | 418.16B |
| AbbVie | 354.53B |
| UnitedHealth Group | 244.08B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.52B |
| Novo Nordisk | 223.00B |